SEC 13F Intelligence

Ogorek Anthony Joseph /Ny/ /Adv / LLY

Ogorek Anthony Joseph /Ny/ /Adv’s Eli Lilly & Co Position

Does Ogorek Anthony Joseph /Ny/ /Adv own Eli Lilly & Co (LLY)? Yes9.7K shares worth $9M (+2.45% of its 13F portfolio) as of Q1 2026, down from 12.1K shares the prior filed quarter.

Position Value
$9M
Q1 2026
Shares
9.7K
% of Portfolio
+2.45%
Quarters Held
23
currently held

Position History LLY

Reported value by quarter
Q3 ’20: $22,000Q3 ’20Q4 ’20: $25,000Q1 ’21: $28,000Q2 ’21: $34,000Q2 ’21Q3 ’21: $34,000Q4 ’21: $2MQ1 ’22: $3MQ1 ’22Q2 ’22: $4MQ3 ’22: $4MQ4 ’22: $4MQ4 ’22Q1 ’23: $4MQ2 ’23: $5MQ3 ’23: $6MQ3 ’23Q4 ’23: $7MQ1 ’24: $9MQ2 ’24: $10MQ2 ’24Q3 ’24: $10MQ4 ’24: $9MQ1 ’25: $9MQ1 ’25Q2 ’25: $9MQ3 ’25: $10MQ4 ’25: $13MQ4 ’25Q1 ’26: $9Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 20269.7K$9M+2.45%
Q4 202512.1K$13M+3.57%
Q3 202512.5K$10M+2.72%
Q2 202511.3K$9M+2.73%
Q1 202511.3K$9M+3.08%
Q4 202411.3K$9M+2.77%
Q3 202411.2K$10M+3.39%
Q2 202411.1K$10M+3.51%
Q1 202411.2K$9M+3.02%
Q4 202311.3K$7M+2.39%
Q3 202311.3K$6M+2.40%
Q2 202311.4K$5M+2.05%
Q1 202311.2K$4M+1.58%
Q4 202211.0K$4M+1.75%
Q3 202211.1K$4M+1.70%
Q2 202211.0K$4M+1.64%
Q1 202210.8K$3M+1.26%
Q4 20217.5K$2M+0.88%
Q3 2021150$34,000+0.02%
Q2 2021150$34,000+0.02%
Q1 2021150$28,000+0.01%
Q4 2020150$25,000+0.01%
Q3 2020150$22,000+0.01%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Ogorek Anthony Joseph /Ny/ /Adv’s full portfolio or all institutional holders of LLY.